US Stock MarketDetailed Quotes

PCRX Pacira BioSciences

Watchlist
  • 20.030
  • +0.050+0.25%
Close Jul 26 16:00 ET
  • 20.030
  • 0.0000.00%
Post 20:02 ET
932.32MMarket Cap13.26P/E (TTM)

Pacira BioSciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
156.70%49.1M
6.45%154.65M
13.20%47.58M
4.18%44.44M
45.94%43.5M
-37.85%19.13M
15.56%145.27M
81.08%42.04M
-29.25%42.65M
-1.09%29.81M
Net income from continuing operations
145.96%8.98M
163.72%41.96M
346.19%24.87M
1,666.81%10.86M
29.62%25.76M
-386.12%-19.54M
-62.10%15.91M
-96.92%-10.1M
-103.92%-693K
4.17%19.88M
Operating gains losses
----
--16.93M
--0
---11K
-95.99%11K
62,588.89%16.93M
----
----
----
-88.80%274K
Depreciation and amortization
-6.00%18.43M
-17.41%75.57M
-39.21%18.49M
-8.74%18.43M
-8.68%19.05M
-2.15%19.6M
220.52%91.5M
132.64%30.41M
252.50%20.2M
326.06%20.86M
Deferred tax
147.17%3.46M
296.54%15.62M
160.89%6.6M
600.00%4.91M
428.74%11.44M
-25,417.24%-7.34M
-173.08%-7.95M
-420.90%-10.84M
-86.85%702K
-63.12%2.16M
Other non cash items
-122.93%-3.03M
111.19%2.46M
121.19%854K
534.08%5.92M
11.09%-17.52M
1,522.48%13.21M
-205.97%-21.98M
-143.19%-4.03M
-82.56%933K
-2,338.64%-19.7M
Change In working capital
151.59%8.11M
-178.57%-45.78M
-608.93%-15.65M
-846.02%-8.2M
-19.06%-6.21M
-93.04%-15.72M
12.00%-16.43M
-835.17%-2.21M
-105.64%-867K
61.36%-5.22M
-Change in receivables
-24.56%3.92M
-244.35%-7.16M
-74.56%-8.6M
189.73%2.12M
-688.68%-5.88M
23.18%5.19M
80.07%-2.08M
63.52%-4.93M
-112.87%-2.37M
106.33%998K
-Change in inventory
145.37%7.57M
-433.47%-8.29M
-1,165.71%-7.83M
-215.86%-4.39M
-72.45%847K
160.37%3.09M
155.65%2.49M
138.54%735K
294.81%3.79M
567.17%3.07M
-Change in prepaid assets
146.57%897K
-257.13%-9.64M
-24.50%-2.65M
-198.20%-2.62M
-337.88%-2.44M
54.79%-1.93M
-336.34%-2.7M
-1,006.81%-2.13M
43.98%2.67M
185.73%1.03M
-Change in payables and accrued expense
84.42%-3.51M
-55.49%-21.12M
-42.48%3.05M
39.60%-3.08M
113.09%1.4M
-635.99%-22.49M
-182.37%-13.59M
-59.43%5.29M
-171.95%-5.1M
-415.97%-10.72M
-Change in other current liabilities
-283.14%-771K
178.06%434K
133.42%394K
-265.28%-238K
-134.96%-143K
501.43%421K
-434.62%-556K
-162.32%-1.18M
113.95%144K
-44.50%409K
Cash from discontinued investing activities
Operating cash flow
156.70%49.1M
6.45%154.65M
13.20%47.58M
4.18%44.44M
45.94%43.5M
-37.85%19.13M
15.56%145.27M
81.08%42.04M
-29.25%42.65M
-1.09%29.81M
Investing cash flow
Cash flow from continuing investing activities
-123.47%-15.53M
134.43%77.54M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
131.82%66.18M
-983.14%-225.19M
-83.28%11.19M
-35.46%-47.52M
531.75%19.16M
Net PPE purchase and sale
56.80%-2.84M
49.59%-15.16M
67.26%-1.8M
34.49%-3.39M
70.99%-3.4M
14.38%-6.57M
34.43%-30.08M
40.08%-5.49M
60.38%-5.18M
-11.22%-11.74M
Net business purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Net investment purchase and sale
-117.45%-12.69M
156.83%92.7M
-39.02%10.17M
97.76%-948K
-65.27%10.73M
143.21%72.75M
-136.32%-163.11M
-96.66%16.68M
-92.42%-42.34M
149.89%30.9M
Net other investing changes
----
----
----
----
----
----
-700.00%-32M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-123.47%-15.53M
134.43%77.54M
-25.16%8.37M
90.86%-4.34M
-61.77%7.33M
131.82%66.18M
-983.14%-225.19M
-83.28%11.19M
-35.46%-47.52M
531.75%19.16M
Financing cash flow
Cash flow from continuing financing activities
98.17%-2.82M
54.42%-183.03M
96.96%-1.78M
-257.39%-27.79M
100.29%440K
15.24%-153.91M
-205.47%-401.53M
-116.19%-58.51M
-354.75%-7.78M
-2,700.83%-153.66M
Net issuance payments of debt
98.09%-2.81M
57.74%-180.76M
95.26%-2.81M
-196.66%-27.81M
98.31%-2.81M
23.51%-147.33M
-217.58%-427.69M
-116.32%-59.38M
---9.38M
---166.34M
Proceeds from stock option exercised by employees
--0
-82.63%4.75M
-44.14%1.14M
-98.44%25K
-74.34%3.25M
-96.98%333K
2.57%27.34M
-66.20%2.04M
-47.58%1.6M
74.97%12.68M
Net other financing activities
99.94%-4K
-497.36%-7.02M
---106K
--0
--0
---6.91M
87.90%-1.18M
----
----
----
Cash from discontinued financing activities
Financing cash flow
98.17%-2.82M
54.42%-183.03M
96.96%-1.78M
-257.39%-27.79M
100.29%440K
15.24%-153.91M
-205.47%-401.53M
-116.19%-58.51M
-354.75%-7.78M
-2,700.83%-153.66M
Net cash flow
Beginning cash position
47.21%153.3M
-82.22%104.14M
-9.42%99.12M
-28.88%86.81M
-84.32%35.55M
-82.22%104.14M
485.83%585.58M
-18.36%109.42M
15.40%122.06M
239.96%226.75M
Current changes in cash
144.83%30.75M
110.21%49.16M
1,125.15%54.18M
197.40%12.31M
148.97%51.27M
80.88%-68.59M
-199.14%-481.44M
-101.17%-5.29M
-144.71%-12.64M
-367.92%-104.69M
End cash Position
417.80%184.05M
47.21%153.3M
47.21%153.3M
-9.42%99.12M
-28.88%86.81M
-84.32%35.55M
-82.22%104.14M
-82.22%104.14M
-18.36%109.42M
15.40%122.06M
Free cash flow
268.26%46.27M
21.09%139.49M
25.29%45.79M
9.53%41.04M
121.87%40.1M
-45.64%12.56M
44.27%115.2M
160.13%36.55M
-20.63%37.47M
-7.72%18.07M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 156.70%49.1M6.45%154.65M13.20%47.58M4.18%44.44M45.94%43.5M-37.85%19.13M15.56%145.27M81.08%42.04M-29.25%42.65M-1.09%29.81M
Net income from continuing operations 145.96%8.98M163.72%41.96M346.19%24.87M1,666.81%10.86M29.62%25.76M-386.12%-19.54M-62.10%15.91M-96.92%-10.1M-103.92%-693K4.17%19.88M
Operating gains losses ------16.93M--0---11K-95.99%11K62,588.89%16.93M-------------88.80%274K
Depreciation and amortization -6.00%18.43M-17.41%75.57M-39.21%18.49M-8.74%18.43M-8.68%19.05M-2.15%19.6M220.52%91.5M132.64%30.41M252.50%20.2M326.06%20.86M
Deferred tax 147.17%3.46M296.54%15.62M160.89%6.6M600.00%4.91M428.74%11.44M-25,417.24%-7.34M-173.08%-7.95M-420.90%-10.84M-86.85%702K-63.12%2.16M
Other non cash items -122.93%-3.03M111.19%2.46M121.19%854K534.08%5.92M11.09%-17.52M1,522.48%13.21M-205.97%-21.98M-143.19%-4.03M-82.56%933K-2,338.64%-19.7M
Change In working capital 151.59%8.11M-178.57%-45.78M-608.93%-15.65M-846.02%-8.2M-19.06%-6.21M-93.04%-15.72M12.00%-16.43M-835.17%-2.21M-105.64%-867K61.36%-5.22M
-Change in receivables -24.56%3.92M-244.35%-7.16M-74.56%-8.6M189.73%2.12M-688.68%-5.88M23.18%5.19M80.07%-2.08M63.52%-4.93M-112.87%-2.37M106.33%998K
-Change in inventory 145.37%7.57M-433.47%-8.29M-1,165.71%-7.83M-215.86%-4.39M-72.45%847K160.37%3.09M155.65%2.49M138.54%735K294.81%3.79M567.17%3.07M
-Change in prepaid assets 146.57%897K-257.13%-9.64M-24.50%-2.65M-198.20%-2.62M-337.88%-2.44M54.79%-1.93M-336.34%-2.7M-1,006.81%-2.13M43.98%2.67M185.73%1.03M
-Change in payables and accrued expense 84.42%-3.51M-55.49%-21.12M-42.48%3.05M39.60%-3.08M113.09%1.4M-635.99%-22.49M-182.37%-13.59M-59.43%5.29M-171.95%-5.1M-415.97%-10.72M
-Change in other current liabilities -283.14%-771K178.06%434K133.42%394K-265.28%-238K-134.96%-143K501.43%421K-434.62%-556K-162.32%-1.18M113.95%144K-44.50%409K
Cash from discontinued investing activities
Operating cash flow 156.70%49.1M6.45%154.65M13.20%47.58M4.18%44.44M45.94%43.5M-37.85%19.13M15.56%145.27M81.08%42.04M-29.25%42.65M-1.09%29.81M
Investing cash flow
Cash flow from continuing investing activities -123.47%-15.53M134.43%77.54M-25.16%8.37M90.86%-4.34M-61.77%7.33M131.82%66.18M-983.14%-225.19M-83.28%11.19M-35.46%-47.52M531.75%19.16M
Net PPE purchase and sale 56.80%-2.84M49.59%-15.16M67.26%-1.8M34.49%-3.39M70.99%-3.4M14.38%-6.57M34.43%-30.08M40.08%-5.49M60.38%-5.18M-11.22%-11.74M
Net business purchase and sale ------0------------------0------------
Net investment purchase and sale -117.45%-12.69M156.83%92.7M-39.02%10.17M97.76%-948K-65.27%10.73M143.21%72.75M-136.32%-163.11M-96.66%16.68M-92.42%-42.34M149.89%30.9M
Net other investing changes -------------------------700.00%-32M--0--0--0
Cash from discontinued investing activities
Investing cash flow -123.47%-15.53M134.43%77.54M-25.16%8.37M90.86%-4.34M-61.77%7.33M131.82%66.18M-983.14%-225.19M-83.28%11.19M-35.46%-47.52M531.75%19.16M
Financing cash flow
Cash flow from continuing financing activities 98.17%-2.82M54.42%-183.03M96.96%-1.78M-257.39%-27.79M100.29%440K15.24%-153.91M-205.47%-401.53M-116.19%-58.51M-354.75%-7.78M-2,700.83%-153.66M
Net issuance payments of debt 98.09%-2.81M57.74%-180.76M95.26%-2.81M-196.66%-27.81M98.31%-2.81M23.51%-147.33M-217.58%-427.69M-116.32%-59.38M---9.38M---166.34M
Proceeds from stock option exercised by employees --0-82.63%4.75M-44.14%1.14M-98.44%25K-74.34%3.25M-96.98%333K2.57%27.34M-66.20%2.04M-47.58%1.6M74.97%12.68M
Net other financing activities 99.94%-4K-497.36%-7.02M---106K--0--0---6.91M87.90%-1.18M------------
Cash from discontinued financing activities
Financing cash flow 98.17%-2.82M54.42%-183.03M96.96%-1.78M-257.39%-27.79M100.29%440K15.24%-153.91M-205.47%-401.53M-116.19%-58.51M-354.75%-7.78M-2,700.83%-153.66M
Net cash flow
Beginning cash position 47.21%153.3M-82.22%104.14M-9.42%99.12M-28.88%86.81M-84.32%35.55M-82.22%104.14M485.83%585.58M-18.36%109.42M15.40%122.06M239.96%226.75M
Current changes in cash 144.83%30.75M110.21%49.16M1,125.15%54.18M197.40%12.31M148.97%51.27M80.88%-68.59M-199.14%-481.44M-101.17%-5.29M-144.71%-12.64M-367.92%-104.69M
End cash Position 417.80%184.05M47.21%153.3M47.21%153.3M-9.42%99.12M-28.88%86.81M-84.32%35.55M-82.22%104.14M-82.22%104.14M-18.36%109.42M15.40%122.06M
Free cash flow 268.26%46.27M21.09%139.49M25.29%45.79M9.53%41.04M121.87%40.1M-45.64%12.56M44.27%115.2M160.13%36.55M-20.63%37.47M-7.72%18.07M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg